FDA Drug Application (062833) for BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE by NASKA

Back to FDA Applications sponsored by NASKA

Application Number062833
Product Number001
FormOINTMENT;TOPICAL
Dosage400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE
Active IngredientBACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Active IngredientCount
List of drugs with Active Ingredient BACITRACIN ZINC15
List of drugs with Active Ingredient NEOMYCIN SULFATE49
List of drugs with Active Ingredient POLYMYXIN B SULFATE46


Back to FDA Applications sponsored by NASKA